Automated Breast Ultrasound System Market Predictions Highpoint Enhanced Sales during Forecast Period, 2018-2027

Fact.MR has published a new research report on global automated breast ultrasound system market sizes, upcoming industry trends and growth opportunity through 2018-2027 to its online database that tries to unveil the various scenarios prevailing in the automated breast ultrasound system market. This assessment delivers a smart compilation of primary and secondary data which provides a clear insight about the future plans expected to impact the automated breast ultrasound system market. This study comprises of prominent data which makes it a beneficial source for investors, analysts and industry experts to acquire necessary knowledge associated to the fundamental market trends, opportunities and growth drivers.

Get A Sample Copy of Market Report Here - https://www.factmr.com/connectus/sample?flag=S&rep_id=585

Breast mammography has gained popularity as the standard diagnostic screening tool in the women’s healthcare, aiding detection and intervention of breast cancers in early stages. Prevalence of breast cancer has been increasing significantly over the past few years. The American Cancer Society recorded over 245,000 new cases of breast cancer in 2016 in the U.S. Despite immense research, mammography alone is not effective for all populations of women, particularly in women having dense breast tissues. Ultrasound has gained traction as more portable and less expensive diagnostic imaging tool, as compared to CT and MRI. However, several limitations are associated with the technology such as lengthy test durations, dependence on skill & expertise of operator. In a bid to resolve these concerns, prominent companies such as SonoCine, U-Systems, Inc., and Siemens Healthcare, have developed automated breast ultrasound system (ABUS), which utilizes high-frequency sound waves to provide the physicians with 3D volumetric image. Such 3D images are more beneficial for women with dense breast tissues, as they enable radiologists to examine the breast cancers from various angles and deliver a better interpretation. Moreover, the operator dependency is drastically reduced, as transducer employed in ABUS scans the breast automatically.

A recently compiled report of FactMR envisages the global market for automated breast ultrasound system to record a value CAGR of 9.3% over the period of forecast, 2018 to 2027. Over 1,800 units of automated breast ultrasound systems are foreseen to be sold worldwide by 2027-end.

Increased sensitivity of the FDA-approved ABUS, nearly 97%, when utilized in conjunction with mammography illustrates this technology’s lucrativeness as a screening tool for women with dense breast tissues. However, certain areas of ABUS are required to be addressed prior to its future developments by companies and market penetration, as the technology is relatively new. One such are directly relates to radiologists. Although ABUS curtails the requirement for a skilled operator, radiologists would now need formal training. As the familiarity of radiologists with ABUS is not as similar as that with other imaging technologies, and as scans offered are volumetric 3D images, correct interpretation of these images will further entail the requirement for standardized training for radiologists.

Several studies have been carried out for evaluating influence of 3D automated breast ultrasound system (3D ABUS), when integrated with full-field digital screening mammography (FFDSM). These studies have shown significant improvements in invasive breast cancer diagnosis rate coupled with acceptable recall increase, when 3d ABUS was added to FFDSM in women having ACR3/ACR4 breast density. 3D ABUS has been deemed to be promising adjunct method to the FFDSM programs of high-volume screening centers.

Ask Industry Expert about this Report here – https://www.factmr.com/connectus/sample?flag=AE&rep_id=585

FactMR’s report has identified key players underpinning expansion of the global automated breast ultrasound system market, which include GE Healthcare, Delphinus Medical Technologies, Inc., Siemens AG, SonoCine Inc., and Hitachi, Ltd. Product innovation will continue to be a key strategy among the market players to gain a competitive edge. A breakthrough innovation, called “Automated Breast Volume Scanner (ABVS)” has been recently introduced by Siemens Healthcare, which provides volume images of breasts, and helps in exhaustive screening using ultrasound.

Contact Us

FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/

About FactMR

FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

This release was published on openPR.